RESMED INC — Director's Dealing 2013

May 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-04-29

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-29	ResMed Common Stock	M	30000	$22.535	Acquired	66803.142	Direct
2013-04-29	ResMed Common Stock	S	30000	$47.246	Disposed	36803.142	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-29	ResMed Stock Options	$22.535	M	30000	Disposed	2014-11-27	ResMed Common Stock (30000)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $47.14 to $47.36. The price reported above reflects the weighted average sale price. The reporting person will provide full informaiton regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.